RVI vs Buying AI Stocks Directly: Which Strategy Actually Wins?

RVI is not an ETF. It's a closed-end fund — and that distinction is worth understanding before you decide if it belongs in your portfolio.

Robinhood Ventures I (NYSE: RVI) launched in March 2026 as the first publicly listed vehicle giving retail investors access to Databricks, OpenAI, Stripe, and Databricks. Most of those names you still cannot buy anywhere else — though SpaceX itself went public in June 2026 as SPCX, converting the fund's largest private position into listed stock. That exclusivity is the entire bull case.

But exclusivity has a price. RVI trades at a persistent 15–30% premium to its net asset value, charges roughly 2.5% in annual expenses, and its underlying holdings are illiquid private stakes that won't produce cash until IPO or acquisition. Meanwhile, you could own NVDA — up ~2,000% over five years — with zero premium, zero management fee, and same-day liquidity.

What You're Actually Buying With RVI

The named company positions in RVI's June 30, 2026 disclosure total roughly 29% of the fund, with cash at a further 31.77%. These are not public stocks — they are secondary positions purchased from employees, early investors, or on platforms like Nasdaq Private Market and Forge.

Remaining ~27% spread across additional private tech holdings.

The Direct AI Stocks Alternative

The public AI basket has been extraordinary. These five names give you massive AI exposure with full liquidity and negligible costs:

5-year returns as of mid-2026, approximate. Past performance doesn't guarantee future results.

The NAV Premium and Fee Math

This is where the RVI bull case gets tested. When you buy RVI at a 20% premium to NAV, you're paying $1.20 for every $1.00 of underlying asset value. That gap has to be recovered through outperformance before you even break even.

Combined, a retail investor buying RVI at a 25% premium faces a total hurdle of roughly 37–38% (premium + five years of fees) before they're ahead of simply buying a cost-free position in NVDA. SpaceX's actual June 2026 IPO shows how it can work: shares that last traded privately around a $350B valuation listed at $1.77T (Nasdaq: SPCX) — a 5x markup that comfortably cleared the hurdle for anyone who bought RVI early enough. The catch is that the next such markup has to come from the remaining private holdings, not from a position that is now public stock.

A concrete worked example: start with $10,000 in each strategy and assume both portfolios' underlying holdings appreciate at the same hypothetical 15% per year. The only structural difference is RVI's ~2.5% fee. After five years the direct basket compounds to about $20,100, while RVI nets roughly $17,800 after fees — a gap of about $2,300, or 13% of the starting stake, created entirely by the fee. That math assumes identical underlying returns, though — RVI's private names can capture funding-round markups no public AI basket can, and the fee is the price of that optionality.

When RVI Actually Makes Sense

My Honest Take as a VC

I've made 65+ investments. The best outcomes in my career came from companies like the ones RVI holds — pre-IPO, category-defining, run by founders who won't stop. I understand the appeal viscerally.

But I also know that the institutional investors who got into SpaceX at a $10B valuation and OpenAI at a $30B valuation are in a fundamentally different position than someone buying RVI today at a 20% premium to NAV when SpaceX is already at $350B and OpenAI is at $300B. The asymmetry has compressed significantly.

If you don't have the access or net worth to invest directly in private funds, RVI gives you something real. But go in clear-eyed: you're paying a premium for that access, and the math requires big exits to work. Track the RVI NAV and premium on the RVI dashboard — timing your entry matters here more than with a standard index fund.